Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation

Non-vitamin K antagonist oral anticoagulants (NOACs), or direct oral anticoagulants have not been tested in randomized trials conducted in patients with atrial fibrillation (AF), who had malignant disease. However, their use in cancer patients increases and real-life evidence for their effectiveness...

Full description

Bibliographic Details

Published in:	Anatolian Journal of Cardiology
Main Authors:	Anetta Undas, Leszek Drabik
Format:	Article
Language:	English
Published:	KARE Publishing 2019-12-01
Subjects:	anticoagulation atrial fibrillation bleeding cancer direct oral anticoagulants
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-30766